Patent · US Expired

Treatment process for promoting weight loss employing a substituted .DELTA. 5

US5296481A · kind A · utility

34Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 1992
Grant dateMar 22, 1994
Priority date
Expiry dateApr 10, 2012

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for controlling weight gain or promoting weight loss which includes the step of treating a subject with an effective weight gain controlling or weight loss promoting amount of a substituted .DELTA.5-Androstene which is biologically effective for controlling weight gain or promoting weight loss and biologically ineffective for promoting the synthesis of sex hormones. Steroids believed to provide the desired weight control/weight loss characteristics include: PA0 .DELTA.5-Androstene-3.beta.,7.alpha.-diol-17-one PA0 .DELTA.5-Androstene-3.beta.-ol-7,17-dione PA0 .DELTA.5-Androstene-3.beta.,7.alpha.,17-triol PA0 .DELTA.5-Androstene-3.beta.,17.beta.-diol-7-one and various derivatives thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.